|

Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy

RECRUITINGN/ASponsored by Josephine Connolly-Schoonen
Actively Recruiting
PhaseN/A
SponsorJosephine Connolly-Schoonen
Started2026-11-02
Est. completion2028-10-30
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

This study will examine if a short-term, reduced protein diet for the 3-day period prior to and on the day of each of the first 4 chemotherapy cycles and 4 days prior to primary breast surgery is well tolerated and adhered to by patients with stage II or III estrogen receptor positive (ER+) human epidermal growth factor receptor negative (HER2-) breast cancer (BC) receiving neoadjuvant chemotherapy (NAC).

Eligibility

Age: 18 Years – 75 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* 18-75 years of age at time of consent
* Stage II or III ER+ HER2- breast cancer patients scheduled to receive standard of care neoadjuvant chemotherapy
* Willingness to consume study foods exclusively during the 20 days of prescribed diet

Exclusion Criteria:

* Any food allergy that may result in anaphylactic response or death (due to possible food allergen cross-contamination in the metabolic kitchen)
* Habitual low protein intake, less than or equal to 1.0 g per kilogram adjusted body weight, based on a screening dietary habits questionnaire score
* Vegans or vegetarians that consume dairy and or eggs
* Pregnant or breastfeeding at the time of screening
* Significant mental illness presenting challenges to follow directions and consume the controlled protein diet exclusively
* Body mass index less than or equal to 18 kilograms over meter squared or greater than 35 kilograms over meter squared
* Participating in another study with a diet intervention

Conditions3

Breast CancerCancerHormone Receptor Positive, HER2 Negative Breast Cancer

Locations1 site

Stony Brook Cancer Center
Stony Brook, New York, 11794
Stony Brook University Cancer Clinical Trials Office631-728-7425CancerClinicalTrials@stonybrookmedicine.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.